Calliditas Therapeutics AB (CALT)
21.63
-0.40
(-1.82%)
USD |
NASDAQ |
May 17, 16:00
21.63
0.00 (0.00%)
After-Hours: 20:00
Calliditas Therapeutics 1 Year Total Returns (Daily): 5.22% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 5.22% |
May 16, 2024 | 4.06% |
May 15, 2024 | -13.19% |
May 14, 2024 | -8.76% |
May 13, 2024 | -15.10% |
May 10, 2024 | -16.50% |
May 09, 2024 | -18.35% |
May 08, 2024 | -19.37% |
May 07, 2024 | -19.41% |
May 06, 2024 | -21.40% |
May 03, 2024 | -20.38% |
May 02, 2024 | -19.99% |
May 01, 2024 | -17.43% |
April 30, 2024 | -14.57% |
April 29, 2024 | -20.08% |
April 26, 2024 | -19.95% |
April 25, 2024 | -23.30% |
April 24, 2024 | -26.99% |
April 23, 2024 | -26.06% |
April 22, 2024 | -26.53% |
April 19, 2024 | -26.09% |
April 18, 2024 | -30.18% |
April 17, 2024 | -26.37% |
April 16, 2024 | -28.08% |
April 15, 2024 | -23.43% |
Date | Value |
---|---|
April 12, 2024 | -24.48% |
April 11, 2024 | -18.37% |
April 10, 2024 | -9.27% |
April 09, 2024 | -2.17% |
April 08, 2024 | -6.48% |
April 05, 2024 | -9.31% |
April 04, 2024 | -8.27% |
April 03, 2024 | -9.15% |
April 02, 2024 | -11.35% |
April 01, 2024 | -12.39% |
March 28, 2024 | -6.21% |
March 27, 2024 | -7.05% |
March 26, 2024 | -4.17% |
March 25, 2024 | -4.21% |
March 22, 2024 | -8.40% |
March 21, 2024 | -9.56% |
March 20, 2024 | -9.48% |
March 19, 2024 | -15.32% |
March 18, 2024 | -11.09% |
March 15, 2024 | -11.65% |
March 14, 2024 | -9.22% |
March 13, 2024 | 3.38% |
March 12, 2024 | 31.13% |
March 11, 2024 | 32.20% |
March 08, 2024 | 23.19% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-54.16%
Minimum
May 09 2022
93.77%
Maximum
May 09 2023
-6.74%
Average
-9.31%
Median
Apr 05 2024
1 Year Total Returns (Daily) Benchmarks
DBV Technologies SA | -70.08% |
Cellectis SA | 66.11% |
Adaptimmune Therapeutics PLC | -17.16% |
Akari Therapeutics PLC | -64.18% |
Biodexa Pharmaceuticals Plc | -93.53% |